Oral Solid Dose Development and
Clinical Manufacturing Services
Services
Why Clients Partner
With Corealis Pharma
Corealis is designed around the needs of innovative biotech and pharma companies, combining scientific depth with the agility required to move programs quickly into the clinic.
Flexible & Fast
Our teams work closely with sponsors to adapt quickly as programs evolve, ensuring development strategies stay aligned with clinical goals.
Scientific Quality
With extensive oral solid dosage (OSD) experience solving complex formulation challenges, Corealis develops robust drug products for Phase I and II clinical programs.
Collaboration & Trust Partnerships
Clients consistently describe Corealis as an extension of their internal R&D teams, with open communication, full-access shared problem-solving, and scientific collaboration at every stage.
Facilities Designed for Execution
Our integrated R&D, analytical, and GMP manufacturing facilities in Laval, Canada allow seamless progression from development to clinical manufacturing
Corealis Development Accelerator Timeline
From Molecule to Clinical Supply. A structured development pathway designed to accelerate oral solid dose programs from early formulation to GMP clinical manufacturing. Corealis efficiently provides a flexible approach to typically deliver from project kickoff to clinical trial supply in approximately 4-6 months or less*.
01
Pre-Formulation
API physicochemical characterization
Analytical method evaluation
Compatibility studies
Solubility screening
Analytical Development
Method development and validation
Dissolution
Forced degradation
ICH Stability conditions
04
GMP Clinical Manufacturing
Phase I–II clinical supply
Tablets, capsules, sublingual
Immediate, controlled and delayed release
Process scale-up
05
Packaging & Clinical Supply
Bottles, blisters, sachets
Labeling and patient kits
Global clinical distribution
*Timelines may vary depending on program complexity and development strategy.
“Corealis knows timelines are critical and risk is high, so the right conversation at the right moment can change the trajectory of a program. That’s the value we aim to bring to every event.”
David Leroux-Petersen
Chief Executive Officer, Corealis
Corealis operates more than 60,000 square feet of integrated development and GMP manufacturing facilities located in Laval’s leading life sciences hub, bringing formulation development, analytical testing, and clinical manufacturing together in one environment.
Visiting our facilities provides a first-hand look at how we support complex drug development programs and collaborate with partners.
